Skip to search formSkip to main contentSkip to account menu

Muphoran

Known as: Mustoforan, Servier brand of fotemustine 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

fotemustine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Od serducha do serducha Rozmowa z Katarzyną Urbańską, dyrektor ds. komunikacji w firmie Servier Polska, odpowiedzialną za akcję „Servier dla Serca”.
2012
2012
Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone (B-MuD) for the treatment of relapsed multiple myeloma
Since multiple myeloma (MM) is still not‐curable, the management of relapse remains challenging. Given the known efficacy of… 
2007
2007
Clinical significance of mustoforan in management of malignant glioma
Review
2007
Review
2007
[Clinical significance of mustoforan in management of malignant glioma].
2005
2005
[Experience with use of mustoforan at the Clinical Oncological Dispensary of the Republic of Tatarstan].
2005
2005
[Effectiveness and safety of combined mustoforan, cisplatin and tamoxifen for disseminated cutaneous melanoma (results of the IC4-10036-46-RU trial)].
The multi-center non-randomized clinical study included 38 patients, aged 31-70, with morphologically (histologically and/or… 
2002
2002
Enhancement of fotemustine (Muphoran®) cytotoxicity by amifostine in malignant melanoma cell lines
Fotemustine (Muphoran®, S10036), a nitrosourea derivative active in the treatment of malignant melanoma and primary brain tumors… 
1999
1999
Fotémustine (Muphoran®) chez 22 patients présentant des récidives de gliomes cérébraux de haut grade
La fotemustine est une nitroso-uree de troisieme generation caracterisee par l’adjonction au radical nitroso-uree d’un groupe… 
1999
1999
[Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas].
Fotemustine is a third-generation nitrosourea characterized by a phosphoalanine carrier group grafted onto the nitrosourea… 
1998
1998
Combined treatment of stage IV melanoma patients with amifostine and fotemustine — a pilot study
Amifostine (Ethyol) is a new chemoprotective agent that has been shown to have significant activity in the prevention of nephro… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)